Business Context and Reporting Period
Company: RXi Pharmaceuticals Corporation (Note: Input metadata references "Phio Pharmaceuticals Corp.", but the filing text identifies the registrant as RXi Pharmaceuticals Corporation).
Filing Type: Form 8-K (Current Report).
Reporting Period: Quarter ended September 30, 2012.
Report Date: November 14, 2012.
Business Context: The filing serves to announce the results of operations for the third quarter of 2012. Detailed financial data is contained in a press release furnished as Exhibit 99.1, which is not incorporated by reference into this specific 8-K text.
Key Financial Metrics
The provided text for this Form 8-K does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached press release (Exhibit 99.1), which is not included in the input content.
Status: Filing text does not provide a clear value for specific financial metrics.
Material Changes
The filing text does not explicitly detail material changes versus the prior comparable period. It only confirms that results for the quarter ended September 30, 2012, have been reported.
Guidance, Outlook, and Risks
Management Commentary: The filing states that the Company reported its results of operations on November 14, 2012.
Legal Disclaimer: The information in Item 2.02 and the attached press release will not be treated as "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and will not be incorporated by reference into other filings unless expressly stated.
Guidance/Risks: No specific guidance, outlook, risks, contingencies, or unusual items are described in the text of this 8-K.
Investor Verification Checklist
- Verify the correct registrant name (RXi Pharmaceuticals Corporation vs. Phio Pharmaceuticals Corp.) to ensure data accuracy.
- Locate and review Exhibit 99.1 (Press Release dated November 14, 2012) for actual financial figures, as they are absent from the 8-K body text.
- Confirm the specific operational results for the quarter ended September 30, 2012, in the external press release.
- Note that the 8-K text explicitly disclaims the "filed" status of the operational results for liability purposes under Section 18 of the Exchange Act.